trending Market Intelligence /marketintelligence/en/news-insights/trending/joqniktoxdovvpapeoj_ea2 content
BY CONTINUING TO USE THIS SITE, YOU ARE AGREEING TO OUR USE OF COOKIES. REVIEW OUR
PRIVACY & COOKIE NOTICE
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Mylan launches generic version of seizure injections

State Of Singapore Online Video Subscription

Power Forecast Briefing: Capacity Shortfalls to Test the Renewable Energy Transition

Episode 43 - More Change, M&A On Horizon For Equity Research Industry

Cable Nets Struggle With Little Revenue Growth Expanding Programming Budgets


Mylan launches generic version of seizure injections

Mylan NV launched a generic version of Pfizer Inc.'s Cerebyx injection in the U.S.

The fosphenytoin sodium injections will be available in single-use vials for the treatment of certain types of seizures.

The treatment had U.S. sales of approximately $36.3 million for the 12 months ending Oct. 31, according to IMS Health.